Anti-programmed cell death 1 therapy triggering diabetic ketoacidosis and fulminant type 1 diabetes.
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.|Department of Internal Medicine, Seoul National University Hospital, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
Sung Hye
SH
Kong
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.|Department of Internal Medicine, Seoul National University Hospital, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
Seo Young
SY
Lee
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.|Department of Internal Medicine, Seoul National University Hospital, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
Ye Seul
YS
Yang
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.|Department of Internal Medicine, Seoul National University Hospital, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
Tae Min
TM
Kim
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. shkwak@snu.ac.kr.|Department of Internal Medicine, Seoul National University Hospital, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Korea. shkwak@snu.ac.kr.
Soo Heon
SH
Kwak